← Back to Clinical Trials
Recruiting NCT06554314
NCT06554314 Effect of Probiotics on Regulating Gut Health and Blood Lipid in Adults
◆ AI Clinical Summary
Plain-language summary for patients
| NCT ID | NCT06554314 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chung Shan Medical University |
| Condition | Obesity |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2024-05-17 |
| Primary Completion | 2024-12-31 |
Trial Parameters
Condition Obesity
Sponsor Chung Shan Medical University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 50
Sex ALL
Min Age 20 Years
Max Age 65 Years
Start Date 2024-05-17
Completion 2024-12-31
Interventions
probiotics
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
The purpose of this study was to evaluate the efficacy of 1 capsules (300 mg per capsule) of Nutrarex Probiotic Capsules per day in regulating gut health and blood lipid in adults by clinical trial.
Eligibility Criteria
Inclusion Criteria: * male or female participants * aged 20-65 years old * body mass index in 25-27 kg/m2 or body fat \> 25% for men and \> 30% for women Exclusion Criteria: * cancer, chronic heart disease, use drugs which pharmacological effects may affect immunity having systemic infections * using probiotics.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology